Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K E Akerman

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Alaproclate acts as a potent, reversible and noncompetitive antagonist of the NMDA receptor coupled ion flowA Wilkinson, M Courtney, A Westlind-Danielsson, et al.
Toxicon : Official Journal of the International Society on Toxinology|September 9, 2000
Kinetic evidence for different mechanisms of interaction of black mamba toxins MT alpha and MT beta with muscarinic receptorsM Jolkkonen, A Oras, T Toomela, et al.
Cancer Research|June 1, 1990
Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cellsA M Jalava, J Heikkilä, G Akerlind, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1995
Real-time measurement of cell permeabilization with low-molecular-weight membranolytic agentsM Virta, K E Akerman, P Saviranta, et al.
Cellular Immunology|October 1, 1995
Rapid Ca2+ mobilization in single LGL cells upon interaction with K562 target cells--role of the CD18 and CD16 moleculesC Lindqvist, C Holmberg, C Oetken, et al.
The Biochemical Journal|February 1, 1993
Inhibition of inositol 1,4,5-trisphosphate 5-phosphatase by micromolar concentrations of disulfiram and its analoguesC J Fowler, G Brännström, P C Ahlgren, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression systemJ P Kukkonen, J Näsman, P Ojala, et al.
FEBS Letters|August 4, 1998
Endogenous extracellular purine nucleotides redirect alpha2-adrenoceptor signalingK E Akerman, J Näsman, P E Lund, et al.
Current Protocols in Neuroscience|April 23, 2008
Measurement of chloride movement in neuronal preparationsR D Schwartz-Bloom, A C Engblom, K E Akerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Muscarinic receptor subtypes in human neuroblastoma cell lines SH-SY5Y and IMR-32 as determined by receptor binding, Ca++ mobilization and northern blottingJ Kukkonen, P Ojala, J Näsman, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1994
Alaproclate acts as a potent, reversible and noncompetitive antagonist of the NMDA receptor coupled ion flowA Wilkinson, M Courtney, A Westlind-Danielsson, et al.
Toxicon : Official Journal of the International Society on Toxinology|September 9, 2000
Kinetic evidence for different mechanisms of interaction of black mamba toxins MT alpha and MT beta with muscarinic receptorsM Jolkkonen, A Oras, T Toomela, et al.
Cancer Research|June 1, 1990
Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cellsA M Jalava, J Heikkilä, G Akerlind, et al.
The Journal of Antimicrobial Chemotherapy|August 1, 1995
Real-time measurement of cell permeabilization with low-molecular-weight membranolytic agentsM Virta, K E Akerman, P Saviranta, et al.
Cellular Immunology|October 1, 1995
Rapid Ca2+ mobilization in single LGL cells upon interaction with K562 target cells--role of the CD18 and CD16 moleculesC Lindqvist, C Holmberg, C Oetken, et al.
The Biochemical Journal|February 1, 1993
Inhibition of inositol 1,4,5-trisphosphate 5-phosphatase by micromolar concentrations of disulfiram and its analoguesC J Fowler, G Brännström, P C Ahlgren, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1996
Functional properties of muscarinic receptor subtypes Hm1, Hm3 and Hm5 expressed in Sf9 cells using the baculovirus expression systemJ P Kukkonen, J Näsman, P Ojala, et al.
FEBS Letters|August 4, 1998
Endogenous extracellular purine nucleotides redirect alpha2-adrenoceptor signalingK E Akerman, J Näsman, P E Lund, et al.
Current Protocols in Neuroscience|April 23, 2008
Measurement of chloride movement in neuronal preparationsR D Schwartz-Bloom, A C Engblom, K E Akerman, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1992
Muscarinic receptor subtypes in human neuroblastoma cell lines SH-SY5Y and IMR-32 as determined by receptor binding, Ca++ mobilization and northern blottingJ Kukkonen, P Ojala, J Näsman, et al.
Pageof 15